HALEON PLC-ADR (HLN) Stock Fundamental Analysis

NYSE:HLN • US4055521003

11.2 USD
+0.04 (+0.36%)
At close: Feb 13, 2026
11.2 USD
0 (0%)
After Hours: 2/13/2026, 8:15:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall HLN gets a fundamental rating of 5 out of 10. We evaluated HLN against 191 industry peers in the Pharmaceuticals industry. HLN has an excellent profitability rating, but there are some minor concerns on its financial health. HLN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • HLN had positive earnings in the past year.
  • HLN had a positive operating cash flow in the past year.
  • HLN had positive earnings in each of the past 5 years.
  • HLN had a positive operating cash flow in each of the past 5 years.
HLN Yearly Net Income VS EBIT VS OCF VS FCFHLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • HLN's Return On Assets of 4.20% is amongst the best of the industry. HLN outperforms 85.34% of its industry peers.
  • Looking at the Return On Equity, with a value of 8.92%, HLN belongs to the top of the industry, outperforming 84.29% of the companies in the same industry.
  • HLN has a better Return On Invested Capital (6.11%) than 83.77% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HLN is significantly below the industry average of 12.64%.
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROIC 6.11%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
HLN Yearly ROA, ROE, ROICHLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

  • HLN has a Profit Margin of 12.84%. This is amongst the best in the industry. HLN outperforms 85.34% of its industry peers.
  • HLN's Profit Margin has improved in the last couple of years.
  • HLN has a Operating Margin of 21.31%. This is amongst the best in the industry. HLN outperforms 89.53% of its industry peers.
  • In the last couple of years the Operating Margin of HLN has grown nicely.
  • HLN has a better Gross Margin (60.75%) than 70.68% of its industry peers.
  • HLN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
HLN Yearly Profit, Operating, Gross MarginsHLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLN is destroying value.
  • HLN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, HLN has less shares outstanding
  • The debt/assets ratio for HLN is higher compared to a year ago.
HLN Yearly Shares OutstandingHLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
HLN Yearly Total Debt VS Total AssetsHLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.42 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • HLN has a Altman-Z score of 2.42. This is in the better half of the industry: HLN outperforms 63.87% of its industry peers.
  • The Debt to FCF ratio of HLN is 5.11, which is a neutral value as it means it would take HLN, 5.11 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.11, HLN belongs to the top of the industry, outperforming 83.77% of the companies in the same industry.
  • HLN has a Debt/Equity ratio of 0.53. This is a neutral value indicating HLN is somewhat dependend on debt financing.
  • HLN's Debt to Equity ratio of 0.53 is on the low side compared to the rest of the industry. HLN is outperformed by 63.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Altman-Z 2.42
ROIC/WACC0.7
WACC8.7%
HLN Yearly LT Debt VS Equity VS FCFHLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that HLN may have some problems paying its short term obligations.
  • With a Current ratio value of 0.98, HLN is not doing good in the industry: 85.86% of the companies in the same industry are doing better.
  • HLN has a Quick Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HLN has a Quick ratio of 0.78. This is amonst the worse of the industry: HLN underperforms 84.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.78
HLN Yearly Current Assets VS Current LiabilitesHLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.59% over the past year.
  • The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
  • Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
  • The Revenue has been growing slightly by 5.78% on average over the past years.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%0.68%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.15% on average over the next years.
  • The Revenue is expected to grow by 3.27% on average over the next years.
EPS Next Y5.72%
EPS Next 2Y7.77%
EPS Next 3Y8.45%
EPS Next 5Y7.15%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HLN Yearly Revenue VS EstimatesHLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
HLN Yearly EPS VS EstimatesHLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.40 indicates a rather expensive valuation of HLN.
  • HLN's Price/Earnings ratio is rather cheap when compared to the industry. HLN is cheaper than 80.63% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of HLN to the average of the S&P500 Index (27.97), we can say HLN is valued inline with the index average.
  • HLN is valuated rather expensively with a Price/Forward Earnings ratio of 19.21.
  • 79.58% of the companies in the same industry are more expensive than HLN, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of HLN to the average of the S&P500 Index (27.96), we can say HLN is valued slightly cheaper.
Industry RankSector Rank
PE 22.4
Fwd PE 19.21
HLN Price Earnings VS Forward Price EarningsHLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HLN is valued cheaply inside the industry as 82.72% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, HLN is valued cheaper than 86.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.48
EV/EBITDA 16.38
HLN Per share dataHLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • HLN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.92
PEG (5Y)1.28
EPS Next 2Y7.77%
EPS Next 3Y8.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • HLN has a Yearly Dividend Yield of 1.67%. Purely for dividend investing, there may be better candidates out there.
  • HLN's Dividend Yield is rather good when compared to the industry average which is at 1.18. HLN pays more dividend than 92.15% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, HLN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • HLN has paid a dividend for at least 10 years, which is a reliable track record.
  • HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
HLN Yearly Dividends per shareHLN Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 39.53% of the earnings are spent on dividend by HLN. This is a low number and sustainable payout ratio.
DP39.53%
EPS Next 2Y7.77%
EPS Next 3Y8.45%
HLN Yearly Income VS Free CF VS DividendHLN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
HLN Dividend Payout.HLN Dividend Payout, showing the Payout Ratio.HLN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HALEON PLC-ADR

NYSE:HLN (2/13/2026, 8:15:00 PM)

After market: 11.2 0 (0%)

11.2

+0.04 (+0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30
Earnings (Next)02-25
Inst Owners58.32%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap49.87B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts80
Price Target12.18 (8.75%)
Short Float %0.45%
Short Ratio2.22
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.36%
PT rev (3m)8.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)0.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 22.4
Fwd PE 19.21
P/S 3.26
P/FCF 18.48
P/OCF 15.93
P/B 2.27
P/tB N/A
EV/EBITDA 16.38
EPS(TTM)0.5
EY4.46%
EPS(NY)0.58
Fwd EY5.21%
FCF(TTM)0.61
FCFY5.41%
OCF(TTM)0.7
OCFY6.28%
SpS3.43
BVpS4.94
TBVpS-3.07
PEG (NY)3.92
PEG (5Y)1.28
Graham Number7.46
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROCE 8.4%
ROIC 6.11%
ROICexc 6.63%
ROICexgc 4145.85%
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
FCFM 17.65%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Debt/EBITDA 3.18
Cap/Depr 98.15%
Cap/Sales 2.83%
Interest Coverage 6.65
Cash Conversion 84.66%
Profit Quality 137.52%
Current Ratio 0.98
Quick Ratio 0.78
Altman-Z 2.42
F-Score6
WACC8.7%
ROIC/WACC0.7
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.72%
EPS Next 2Y7.77%
EPS Next 3Y8.45%
EPS Next 5Y7.15%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%0.68%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.27%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.42%
EBIT Next 5Y7.75%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%

HALEON PLC-ADR / HLN FAQ

Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?

ChartMill assigns a fundamental rating of 5 / 10 to HLN.


Can you provide the valuation status for HALEON PLC-ADR?

ChartMill assigns a valuation rating of 5 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.


How profitable is HALEON PLC-ADR (HLN) stock?

HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for HLN stock?

The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 22.4 and the Price/Book (PB) ratio is 2.27.


Can you provide the dividend sustainability for HLN stock?

The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 39.53%.